Oxygenta Pharmaceutical Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

19.94

14.95

23.01

37.52

11.85

Operating profit

-5.61

-2.54

-0.59

2.07

-0.03

Interest

0.64

0.35

0.38

0.54

0.26

Gross profit

-6.25

-2.89

-0.97

1.53

-0.28

EPS (Rs)

-2.31

-2.84

-0.49

0.06

-0.76

Other income

-

-

-

-

0.01

Stock adjustment

-1.21

-1.90

2.92

1.63

-7.34

Raw material

19.76

12.66

14.49

28.19

15.22

Power and fuel

-

-

-

-

-

Employee expenses

0.50

0.43

0.15

0.18

0.31

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

6.49

6.31

6.05

5.45

3.69

Provisions made

-

-

-

-

-

Depreciation

1.33

0.80

0.79

0.81

0.50

Taxation

-0.02

-

0.12

-

-

Net profit / loss

-7.72

-4.03

-0.70

0.09

-0.78

Extra ordinary item

-0.16

-0.34

1.18

-0.64

-

Prior year adjustments

-

-

-

-

-

Equity capital

33.48

14.20

14.20

14.20

10.20

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-28.14

-17.02

-2.58

5.52

-0.28

GPM (%)

-31.32

-

-4.23

4.08

-2.35

NPM (%)

-38.71

-

-3.03

0.23

-6.57